Novartis sells two cancer drugs to Laekna

The Shanghai-based company now has the global rights to two oral clinical-stage meds, which Novartis originally nabbed from GlaxoSmithKline several year ago
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news